Co-Diagnostics, Inc. (CODX)

Co-Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	14.92	22.97	88.61	42.98	0.89
Short-Term Investments	43.63	58.36	1.33	4.34	0
Cash & Cash Equivalents	58.55	81.34	89.94	47.31	0.89
Cash Growth	-28.02%	-9.56%	90.09%	5197.30%	-6.01%
Receivables	0.3	3.45	20.84	12.14	0.13
Inventory	1.66	5.31	2	8	0.2
Other Current Assets	1.62	2.63	2.34	0.37	0.36
Total Current Assets	62.14	92.73	115.12	67.81	1.58
Property, Plant & Equipment	6	2.91	1.93	0.95	0.2
Long-Term Investments	0.77	0.67	1.08	1.93	0.43
Goodwill and Intangibles	26.4	26.77	41.9	0	0
Other Long-Term Assets	0	0	0	0.55	0
Total Long-Term Assets	33.18	30.35	44.91	3.42	0.63
Total Assets	95.32	123.09	160.03	71.24	2.22
Accounts Payable	1.48	0.95	0.61	0.6	0.01
Deferred Revenue	0.36	0	0.15	0.31	0
Current Debt	0.84	0.3	0	0	0
Other Current Liabilities	3.06	2.62	11.84	3.16	0.32
Total Current Liabilities	5.75	3.87	12.6	4.06	0.33
Long-Term Debt	2.15	0.05	0	0	0
Other Long-Term Liabilities	1.41	4.64	12.96	0.48	0.15
Total Long-Term Liabilities	3.56	4.69	12.96	0.48	0.15
Total Liabilities	9.31	8.57	25.56	4.54	0.48
Total Debt	2.99	0.35	0	0	0
Debt Growth	759.56%	-	-	-	-
Retained Earnings	4.6	39.93	54.17	17.51	-24.97
Comprehensive Income	0.15	0.29	0	0	0
Shareholders' Equity	86.01	114.52	134.48	66.7	1.74
Net Cash / Debt	55.56	80.99	89.94	47.31	0.89
Net Cash / Debt Growth	-31.40%	-9.95%	90.09%	5197.30%	-
Net Cash Per Share	1.89	2.57	3.01	1.69	0.05
Working Capital	56.39	88.86	102.52	63.75	1.26
Book Value Per Share	2.93	3.64	4.66	2.50	0.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).